samedan logo

 
 
spacer
home > pmps > spring 2019 > easing late-stage customisation in pharmaceutical logistics
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Easing Late-Stage Customisation in Pharmaceutical Logistics

Late-stage customisation in pharmaceutical manufacturing includes, for example, adding variable data to labels or packaging that are pre-printed. This allows the manufacturer to customise product labelling for certain markets, customers, or products without having to stock individual packaging materials for each possible variant. Additionally, the flexible production of smaller batch sizes creates new requirements for automatic and fast changeovers. How can pharma manufacturers implement a tamper-evident, flexible solution for low and medium volume production?

Choosing Late- Stage Customisation

Government organisations around the world have initiated or already implemented laws and regulations that aim to ensure patient and consumer safety by preventing falsified and counterfeit medicines from illegally entering the supply chain. The EMA defines falsified medicines as those which may come in fake packaging or contain the wrong ingredients or low levels of the active ingredients (1). Counterfeit medicines are those that infringe trademark law or do not comply with intellectual property rights. Falsified and counterfeit medicines can pose serious risks to patients and consumers. For example, in the EU, pharmaceuticals need to be labelled and packaged specifically for each member state in which they are marketed, according to each country’s individual requirements. Counterfeiting can be reduced significantly by implementing product serialisation, which requires a system to track and trace medicines throughout the entire supply chain. Serialisation of prescription medicines will become mandatory in the EU on 9 February 2019. Similar regulations are already in place in other regions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Arndt Neues is Omron’s Team Manager for key account food and commodity original equipment manufacturers. A graduate engineer, he joined Omron in 2003 after initially working as an Export Manager for Geutebrück, responsible for CCTV systems in high-security areas. This was followed by three years as a Product Manager at ERSA. Arndt was first appointed as the Product Manager for sensors. Since then, he has held several positions in the company before his current post. In recent years, Arndt has published several articles on the topics of inspection solutions and optics.
spacer
Arndt Neues
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Anaqua and PatSnap Team Up to Deliver an End-to-End Pharma IP Management Solution

BOSTON, December 7, 2022 – Anaqua, the leading provider of innovation and intellectual property management technology, today announced it is partnering with innovation intelligence platform PatSnap. The collaboration will deliver an enhanced IP management solution to provide Anaqua’s pharmaceutical industry clients with a more detailed and informed view of the market and competitive landscape for key use cases. The combined Anaqua AQX® Pharma and PatSnap Synapse solutions will help AQX Pharma clients further enhance competitiveness, keep up with the fast-paced requirements of the current market, eliminate duplicated work across functions, as well as identify and realize new areas of investment.
More info >>

White Papers

8 Ways To Reduce Tablet Manufacturing Costs

Natoli Engineering Company, Inc.

It’s no surprise that in today’s economy, companies are facing budget cuts across the board. In an effort to address these challenges, this list of 8 Ways to Reduce Tablet Manufacturing Costs was compiled.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement